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The direct impact of osteoarthritis (OA) in real life settings has 
been poorly studied on large population. However, this informa- 
tion is essential to identify the burden of the disease. 
Methods: In 2000, a nation-wide survey of more than 5000 physi- 
cians, either general practitioners (90.3%) or rheumatologists 
(9.7%), representative of the French medical demography, was 
conducted. Each recruited the first two patients consulting for 
hip, knee or hand OA after the onset of the survey, and asked 
them to complete a questionnaire about activities of daily living. 
Results: Clinical and social information was available for 10412 
OA patients, mean age 66.2 ±10.2 years, sex ratio (F :M) 1.96. For 
84.5% of them, OA diagnosis was based on both clinical and 
radiographic findings. 69.2% of the respondents were retired, 
17.4% were workers, 10.2% unpaid household workers, and 3.2 
unemployed or on permanent disability. 
Limitation in activities of daily living 81.5% 
grocery shopping 57.3% personal care 10.5% 
house cleaning 43.0% meal preparation 10.2% 
dressing 21.5% other 14.2% 
Modification of activities 76.9% 
gardening 47.9% sports 20.8% 
odd jobs around the 
house 22.8% other 16.5% 
Mobility problems 61.9% 
outside 98.8% at home 20.7% 
Workers (17.4%) 
limitation in their 64.4% missed work 21.6% 
professional activity 
These limitations induced expenditures not covered by public or 
private health care insurance for 20.4% of the respondents, main- 
ly related to moving (10.5%), house keeping (9.5%) and grocery 
delivery (8.1%). 
Conclusion: This study provides representative data about the 
functional impact of OA in daily life settings. It shows significant 
impact of OA-relate disability in retired people as well as those 
involved in labor market activities. 
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PROTECTIVE EFFECT OF THE CHONDROPROTECTIVE 
AGENTS GLUCOSAMINE HCL AND CHONDROITIN SULFATE 
(COSAMIN®DS) ON ARTICULAR CARTILAGE EXPOSED TO 
NONSTEROIDAL ANTI- INFLAMMATORY AGENTS 
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These studies evaluated the ability of a combination of "chon- 
droprotective" agents, glucosamine HCI (Gin), and chondroitin 
sulfate (CS) with manganese ascorbate (MnAs) (Cosarnin® DS, 
Nutrainax® Labs Inc., Edgewood, MD.) to protect articular carti- 
lage from the potentially adverse metabolic effects of nons- 
teroidal anti-inflammatory agents (NSAIDs). Articular cartilage 
explant and high-density monolayer cultures were assayed for 
$25 
proteoglycan (PG) synthesis and degradation following timed 
exposure to therapeutic dosages of NSAIDs. A time-dependent 
comparison was made of the cartilage response to NSAIDs in tis- 
sues from young (15 months) steers and aged (7-10 years) 
Holsteins. 
Methods: Cartilage explants and high-density monolayer cul- 
tures were cultured to a metabolic steady state prior to exposure 
to the NSAIDs etodolac, celecoxib, aspirin and indomethacin. PG 
synthesis into the cell layer or explant was monitored at 8, 24 and 
144 hours by pulse labeling with 35 SO 4 . PG degradation was 
assayed by counting radioactivity released into the media over a 
24-hour period from 35 SO 4 prelabeled cultures. Statistical sig- 
nificance was determined by the KruskaI-Wallis nonparametric 
analysis of variance. 
Results: A dose-dependent stimulated of monolayer cultures by 
a combination of Gin, CS and MnAs was apparent within 5 hours 
of exposure, in contrast, explants required at least 24 hours for up 
regulation of synthetic activity which was inversely related to 
dose. Cosamin®DS clearly eliminated etodolac and celecoxib- 
induced inhibition of cartilage synthetic activity in tissue from 
aged animals. Similarly, in aged animals etodolac but not cele- 
coxib increased PG breakdown which was prevented by simulta- 
neous exposure to Cosamin® DS. lndomethacin had little effect 
at 10 ug/ml while aspirin stimulated synthetic activity in aged tis- 
sue by 40% after 72 and 144 hours exposure..Addition of 
Cosamin® DS slightly augmented this response. 
Conclusions: In vitro, cartilage matrix does not appear to be an 
impenetrable barrier to CS, one of the components of Cosamin® 
DS. The inverse relationship between Cosainin® DS dose and 
level of up regulation may have clinical significance. In summary, 
this combination of agents may be useful adjunct therapy for 
preservation of articular cartilage by counteracting the adverse 
metabolic effects of NSAIDs, 
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Aim: To investigate the long-term effects (12 days) of 
avocado/soybean unsaponifiable (ASU; 1 part avocado and 2 
parts soybean, Piascledine, Pharmascience-Expanscience, 
Courbevoie, France) mixture on the metabolism of human chon- 
drocytes cultured in alginate beads. 
Method: Enzymatically isolated 5steoarthritic (OA) chondrocytes 
were cultured in alginate beads in a well-defined culture medium 
for 12 days. The DNA content was measured according to a flu- 
orimetric method. Interleukin-6 and -8 (IL-6, IL-8), stromelysin 
(MMP-3) and aggrecan (AGG) productions were assayed by spe- 
cific enzyme amplified sensitivity immunoassays (EASIA), and 
prostaglandin E 2 (PGE2) production by a specific radioim- 
munoassay. 
Results: In the basal conditions, ASU at 10 Xg/mt, increased by 
35 % the AGG contained in the alginate beads. Furthermore, ASU 
significantly inhibited IL-6, IL-8 and MMP-3 syntheses. IL-lb 
stimulated IL-6, IL-8, PGE 2 and MMP-3 productions and fully 
blocked AGG synthesis. When it was added simultaneously with 
IL-1, ASU partially reversed the IL-l~-stimulatory effect on 11--6, 
